Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Continuation vs Interruption in Colonoscopy
NCT07052799Phase 3Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Feb 2026
- Primary completion
- Dec 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing aspirin with Placebo (2 arms). Primary endpoint: Cardiovascular events at 30 days. Started Feb 2026; status: recruiting.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT07052799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07052799.